United Therapeutics (UTHR) Asset Writedowns and Impairment (2017 - 2022)
United Therapeutics (UTHR) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $4.2 million as the latest value for Q4 2022.
- Quarterly Asset Writedowns and Impairment rose 104.46% to $4.2 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Sep 2024, down 62.5% year-over-year, with the annual reading at $21.7 million for FY2025, N/A changed from the prior year.
- Asset Writedowns and Impairment hit $4.2 million in Q4 2022 for United Therapeutics, down from $7.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $107.3 million in Q2 2021 to a low of -$94.2 million in Q4 2021.
- Historically, Asset Writedowns and Impairment has averaged $5.5 million across 4 years, with a median of $5.8 million in 2020.
- Biggest five-year swings in Asset Writedowns and Impairment: surged 1450.0% in 2020 and later soared 104.46% in 2022.
- Year by year, Asset Writedowns and Impairment stood at $8.8 million in 2019, then crashed by 38.64% to $5.4 million in 2020, then tumbled by 1844.44% to -$94.2 million in 2021, then soared by 104.46% to $4.2 million in 2022.
- Business Quant data shows Asset Writedowns and Impairment for UTHR at $4.2 million in Q4 2022, $7.0 million in Q3 2022, and -$94.2 million in Q4 2021.